| abstract |
The present invention provides compounds useful as inhibitors of c-Met tyrosine kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions for the treatment of various proliferative disorders. The invention also provides a pharmaceutical composition comprising a compound of formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle. Furthermore, the present invention provides a method of treating or reducing the severity of a proliferative disease, condition or disorder in a patient, comprising administering to the patient a therapeutically effective amount of a compound of formula I or a pharmaceutical composition thereof. provide. |